Improvement Of Radiological Disease On Ct After Neoadjuvant Chemotherapy May Not Correlate With Chemotherapy Response Score (Crs) In Advanced Tubo-Ovarian High-Grade Serous Ovarian Carcinoma

Objective: Chemotherapy response score (CRS) is a reproducible histopathologic scoring system that has shown prognostic significance for measuring response to neoadjuvant chemotherapy (NACT) in interval-cytoreduced specimens of tubo-ovarian high-grade serous carcinoma (TOHGSC). CRS does not include radiological data. The aim of this study was to assess whether radiological improvement in disease following NACT correlates with CRS.